Tracey McCain
Compliance Officer bij BLUEPRINT MEDICINES CORPORATION
Vermogen: 6 M $ op 31-03-2024
Profiel
Tracey L.
McCain is an Independent Director at Kiniksa Pharmaceuticals Ltd.
and Secretary, Chief Legal & Compliance Officer at Blueprint Medicines Corp.
She was previously a General Counsel at Genzyme Corp.
and a Senior Vice President & Head-Legal at Genzyme Therapeutics Ltd.
She also worked as an Associate at Palmer & Dodge LLP.
McCain received her undergraduate degree from the University of Pennsylvania and her graduate degree from Columbia Law School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-03-2024 | 60 498 ( 0.10% ) | 6 M $ | 31-03-2024 | |
| 29-06-2023 | 5 000 ( 0.01% ) | 98 650 $ | 31-03-2024 |
Actieve functies van Tracey McCain
| Bedrijven | Functie | Begin |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Compliance Officer | 06-09-2016 |
| KINIKSA PHARMACEUTICALS, LTD. | Director/Board Member | 01-02-2018 |
Eerdere bekende functies van Tracey McCain
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOGEN, INC. | Director/Board Member | 12-02-2024 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | General Counsel | 02-09-2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01-09-2016 |
| Palmer & Dodge LLP | Corporate Officer/Principal | - |
Opleiding van Tracey McCain
| University of Pennsylvania | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
